Treatment of psoriasis vulgaris using low-dose naltrexone Alanna C. Bridgman, MSc, Mark G. Kirchhof, MD, PhD, FRCPC JAAD Case Reports Volume 4, Issue 8, Pages 827-829 (September 2018) DOI: 10.1016/j.jdcr.2018.06.001 Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Clinical response of psoriasis to low-dose naltrexone. Psoriasis disease status as measured by BSA and PASI in relation to treatments over 27-month timeline. JAAD Case Reports 2018 4, 827-829DOI: (10.1016/j.jdcr.2018.06.001) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions